Impact of Bcl-2 and Ha-ras on keratinocytes in organotypic culture

Journal of Investigative Dermatology

Volumn 116, Issue 3, 2001, Pages 366-373

  Delehedde, Maryse ^a   Cho, Song H ^a   Hamm, Rebecca ^a   Brisbay, Shawn ^a   Ananthaswamy, Honnavara N ^a   Kripke, Margaret ^a   McDonnell, Timothy J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Cancer; Differentiation; HaCaT; Oncogene

Indexed keywords

CYCLINE; CYTOKERATIN; CYTOKERATIN K1; CYTOKERATIN K14; INVOLUCRIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE H RAS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION;

EID: 0035092921     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01260.x     Document Type: Article

References (47)

1. Normal growth and differentiation in a spontaneously immortalized neardiploid human keratinocyte cell line. NIKS
2. Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the air-liquid interface
3. Human epidermis reconstructed by culture: Is it 'normal'
4. Three dimensional culture of human keratinocytes on a dermal equivalent
5. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture
6. Diminished cell proliferation associated with the death-protective activity of bcl-2
7. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line
8. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy
9. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature
10. Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line
11. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic cell growth in cutaneous basal cell carcinoma
12. Differential responsiveness of human breast cancer cells to basic fibroblast growth factor. A cell kinetics study
13. Altered expression of bcl-2 family member proteins in non-melanoma skin cancer
14. Inhibitory function of p21 Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
15. Alterations in murine keratinocyte differentiation induced by activated ras Ha genes are mediated by protein kinase C-alpha
16. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation
17. WAF1, a potential mediator of p53 tumor suppression
18. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells
19. Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2
20. Integration of positive and negative growth signals during ras pathway activation in vivo
21. Epidermal differentiation and keratin gene expression
22. Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes
23. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene
24. Cell death by apoptosis in epidermal biology
25. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
26. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
27. The anti-apoptosis function of bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
28. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation
29. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis
30. P53 mutations in human immortalized epithelial cell lines
31. Cross talk between cell death and cell cycle progression: Bcl-2 regulated NFAT-mediated activation
32. Keratinocytes become terminally differentiated in a process involving programmed cell death
33. Programmed cell death in terminally differentiating keratinocytes: Role of endogenous endonuclease
34. Bcl-2 expression in primary malignancies of the skin
35. Overexpression of Bcl-2 protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecis
36. Bcl-2 expression in epidermal keratinocytic diseases
37. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation
38. N-ras mutation in ultraviolet radiation-induced murine skin cancers
39. Apoptosis in human skin development morphogenesis, periderm and stem cells
40. Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation
41. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo
42. The expression and localization of bcl-2 protein in normal skin and in non-melanoma skin cancers
43. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction and are susceptible to skin tumor formation
44. Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones
45. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts
46. Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma